Covid-19 vaccine candidates move closer to final testing

Pharmaceutical companies working on Covid-19 vaccine candidates are releasing early results and moving into final stage trials, as the world waits to see if they can compress the usual years-long timeline to create such a product.The stakes are high: the coronavirus pandemic has already cost almost 590,000 lives and ravaged the global economy, and it is showing no sign of abating. Countries have poured billions of dollars into vaccine development as a possible exit route.There are glimmers of…

Read the original article at South China Morning Post